⌘K
Loading ticker…
Bristol-Myers Squibb Co. · Healthcare · Pharmaceutical Products
As of 2026-06-26, Bristol-Myers Squibb Co. (BMY) has a 3-month relative strength percentile of 34 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 52. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 2.5%, relative volume 1.63×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
34 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
BMY is in a stage 2 uptrend, week 1. Currently in a 82-day base; basing ADR 2.2% (broad 2.1%). VCP detected: 3 contractions. RS line below base-start high. Distance from 50d / 200d: 0.8% / 6.9%.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
BMY is held by 20 ETFs as of Mar 2026. Top owner: VTI at 0.20% weight, $3.9B notional. Top 3 carry $8.7B.
Top 10 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.20% | $3.9B |
| VOOVanguard S&P 500 ETF | 0.22% | $3.1B |
| IVViShares Core S&P 500 ETF | 0.22% | $1.6B |
| SPYState Street SPDR S&P 500 ETF | 0.22% | $1.4B |
| VTVVanguard Value ETF | 0.51% | $1.1B |
| XLVState Street Health Care Select Sector SPDR ETF | 2.33% | $899M |
| JEPIJPMorgan Equity Premium Income ETF | 1.15% | $504M |
| SPYMState Street SPDR Portfolio S&P 500 ETF | 0.22% | $260M |
| IWDiShares Russell 1000 Value ETF | 0.33% | $229M |
| IVEiShares S&P 500 Value ETF | 0.46% | $213M |
Showing 10 of 20 ETF owners.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | BMY Jan avg: 0.63% median: 1.52% win: 75% σ: 3.83% n: 4 2022-04-12 → 2026-05-29 | BMY Feb avg: 3.30% median: 2.49% win: 75% σ: 7.64% n: 4 2022-04-12 → 2026-05-29 | BMY Mar avg: 1.73% median: 1.40% win: 75% σ: 4.01% n: 4 2022-04-12 → 2026-05-29 | BMY Apr avg: -8.41% median: -3.67% win: 0% σ: 9.16% n: 5 2022-04-12 → 2026-05-29 | BMY May avg: -3.84% median: -3.82% win: 20% σ: 2.60% n: 5 2022-04-12 → 2026-05-29 | BMY Jun avg: -0.44% median: 0.15% win: 50% σ: 2.72% n: 4 2022-04-12 → 2026-05-29 (current) | BMY Jul avg: 0.29% median: -3.47% win: 25% σ: 9.61% n: 4 2022-04-12 → 2026-05-29 | BMY Aug avg: 1.11% median: 2.08% win: 50% σ: 7.65% n: 4 2022-04-12 → 2026-05-29 | BMY Sep avg: -0.30% median: -0.41% win: 50% σ: 5.66% n: 4 2022-04-12 → 2026-05-29 | BMY Oct avg: 1.92% median: 4.97% win: 75% σ: 9.25% n: 4 2022-04-12 → 2026-05-29 | BMY Nov avg: 3.11% median: 4.91% win: 75% σ: 5.04% n: 4 2022-04-12 → 2026-05-29 | BMY Dec avg: -0.33% median: -0.29% win: 50% σ: 8.86% n: 4 2022-04-12 → 2026-05-29 |